-transparent.png){kind=logo}
We report a case of calcium oxalate arthropathy in a woman undergoing intermittent peritoneal dialysis who was not receiving pharmacologic doses of ascorbic acid. She developed acute arthritis, with calcium oxalate crystals in Heberden's and Bouchard's nodes, a phenomenon previously described in gout. Intermittent peritoneal dialysis may be less efficient than hemodialysis in clearing oxalate, and physicians should now consider calcium oxalate-associated arthritis in patients undergoing peritoneal dialysis who are not receiving large doses of ascorbic acid.
Related Publications
A Rosenthal, and
L M Ryan, and
D J McCarty
February 1989,
Seminars in arthritis and rheumatism,
A Rosenthal, and
L M Ryan, and
D J McCarty
October 2006,
Diagnostic cytopathology,
A Rosenthal, and
L M Ryan, and
D J McCarty
January 1994,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Rosenthal, and
L M Ryan, and
D J McCarty
March 1986,
The Medical clinics of North America,
A Rosenthal, and
L M Ryan, and
D J McCarty
March 1984,
Kidney international,
A Rosenthal, and
L M Ryan, and
D J McCarty
March 1999,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
A Rosenthal, and
L M Ryan, and
D J McCarty
November 2000,
Trends in plant science,
A Rosenthal, and
L M Ryan, and
D J McCarty
November 2022,
Microscopy research and technique,
A Rosenthal, and
L M Ryan, and
D J McCarty
June 1990,
Clinical radiology,
A Rosenthal, and
L M Ryan, and
D J McCarty
November 1989,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
